— Know what they know.
Not Investment Advice

FULC NASDAQ

Fulcrum Therapeutics, Inc.
1W: -7.3% 1M: -15.0% 3M: -40.1% YTD: -39.6% 1Y: +1.2% 3Y: +73.4% 5Y: -33.0%
$6.57
-0.02 (-0.30%)
 
Weekly Expected Move ±7.1%
$6 $6 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 27 · $355.5M mcap · 48M float · 2.19% daily turnover · Short 67% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
24.4 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -2179.7%  ·  5Y Avg: -391.9%
Cost Advantage
27
Intangibles
25
Switching Cost
12
Network Effect
43
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. FULC has No discernible competitive edge (24.4/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. Negative ROIC of -2179.7% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$17
Avg Target
$17
High
Based on 14 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 4Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$17.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-24 Truist Financial Gregory Renza $18 $17 -1 +89.8% $8.96
2025-12-11 Truist Financial $14 $18 +4 +42.3% $12.64
2025-12-08 Stifel Nicolaus $3 $25 +22 +77.7% $14.07
2025-12-08 Cantor Fitzgerald Kristen Kluska $23 $24 +1 +74.7% $13.74
2025-12-08 RBC Capital $4 $10 +6 -28.9% $14.06
2025-12-08 Piper Sandler $16 $23 +7 +158.4% $8.90
2025-12-08 H.C. Wainwright $18 $25 +7 +180.9% $8.90
2025-11-24 Truist Financial Initiated $14 +24.0% $11.29
2025-11-24 H.C. Wainwright Andrew Fein $12 $18 +6 +59.4% $11.29
2025-10-30 Piper Sandler $9 $16 +7 +70.9% $9.36
2025-10-21 Leerink Partners $12 $20 +8 +116.9% $9.22
2025-07-29 H.C. Wainwright $4 $12 +8 +58.1% $7.59
2025-05-29 Piper Sandler Edward Tenthoff $18 $9 -9 +27.0% $7.08
2025-05-23 Leerink Partners Joseph Schwartz Initiated $12 +86.3% $6.44
2024-09-13 H.C. Wainwright Andrew Fein Initiated $4 +16.3% $3.44
2024-09-12 RBC Capital Gregory Renza $15 $4 -11 +16.3% $3.44
2024-09-12 Stifel Nicolaus Dae Gon Ha downgraded Fulcrum Therapeutics $22 $3 -19 -15.6% $3.55
2024-09-12 Bank of America Securities Tazeen Ahmad $10 $2 -8 -41.9% $3.44
2024-09-09 Bank of America Securities Tazeen Ahmad Initiated $10 +16.2% $8.61
2024-09-03 RBC Capital Gregory Renza $14 $15 +1 +79.1% $8.37
2024-05-20 Cantor Fitzgerald Kristen Kluska Initiated $23 +204.6% $7.55
2024-05-13 Goldman Sachs Corinne Jenkins $11 $15 +4 +104.1% $7.35
2024-05-13 Stifel Nicolaus Dae Gon Ha Initiated $22 +194.1% $7.48
2024-03-13 RBC Capital Gregory Renza Initiated $14 +23.2% $11.36
2022-11-14 Goldman Sachs Initiated $11 +61.5% $6.81
2022-11-08 Piper Sandler Edward Tenthoff Initiated $18 +182.8% $6.37

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
3
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. FULC receives an overall rating of C+. Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-04-27 C C+
2026-04-01 C+ C
2026-02-24 C- C+
2026-02-06 C C-
2026-01-03 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

Grade A+
Profitability
Balance Sheet
85
Earnings Quality
62
Growth
12
Value
40
Momentum
20
Safety
100
Cash Flow

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
18.43
Safe Zone
Piotroski F-Score
3/9
Beneish M-Score
Ohlson O-Score
-2.38
Bankruptcy prob: 8.5%
Low Risk
Credit Rating
A+
Score: 75.6/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.84x
Accruals: -4.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. FULC scores 18.43, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. FULC scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. FULC's implied 8.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. FULC receives an estimated rating of A+ (score: 75.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.58x
PEG
0.00x
P/S
0.00x
P/B
1.50x
P/FCF
-9.15x
P/OCF
EV/EBITDA
-3.06x
EV/Revenue
EV/EBIT
-3.01x
EV/FCF
-3.74x
Earnings Yield
-13.02%
FCF Yield
-10.93%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. FULC currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.959
EBT / EBIT
×
EBIT Margin
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.059
Assets / Equity
=
ROE
-25.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. FULC's ROE of -25.7% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1722 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.57
Median 1Y
$3.22
5th Pctile
$0.50
95th Pctile
$20.86
Ann. Volatility
110.6%
Analyst Target
$17.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Alex C. Sapir
President and Chief Executive Officer
$650,000 $— $3,251,490
Alan Musso Financial
ancial Officer
$478,100 $— $1,807,125
Curtis Oltmans Legal
Legal Officer and Head of External Affairs
$472,200 $— $1,482,850

CEO Pay Ratio

22738:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,251,490
Avg Employee Cost (SGA/emp): $143
Employees: 200,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
200,000
+392056.9% YoY
Revenue / Employee
Profit / Employee
$-374
NI: $-74,880,000
SGA / Employee
$143
Avg labor cost proxy
R&D / Employee
$281
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -80.4% -82.4% -52.7% -58.5% -67.9% -69.9% -53.5% -53.0% -48.0% -48.1% -44.8% -45.8% -9.3% -8.3% -4.1% -0.2% -30.6% -29.7% -25.3% -25.7% -25.71%
ROA -61.1% -62.6% -44.4% -49.2% -57.2% -58.8% -47.6% -47.1% -42.6% -42.8% -40.2% -41.1% -8.4% -7.4% -3.8% -0.2% -28.2% -27.4% -23.9% -24.3% -24.28%
ROIC 3.3% 3.4% 9.7% 10.7% 12.5% 12.9% -9.4% -9.6% -9.0% -9.3% -8.9% -9.1% -2.6% -2.5% -1.6% -92.5% -6.3% -6.1% -21.3% -21.8% -21.80%
ROCE -71.6% -73.2% -37.6% -41.7% -48.5% -49.9% -53.4% -54.3% -51.0% -52.7% -45.4% -46.1% -13.4% -11.6% -6.8% -3.0% -31.0% -29.6% -22.0% -22.5% -22.48%
Gross Margin -3.0% -2.5% -2.7% -5.9% -12.3% -12.0% -26.1% -55.7% -19.3% -23.0% 41.7% 78.4%
Operating Margin -4.5% -4.2% -4.7% -10.0% -18.2% -20.6% -40.8% -94.7% -31.0% -36.2% -32.1% 65.6%
Net Margin -4.5% -4.2% -4.6% -10.0% -18.1% -20.1% -38.2% -84.0% -27.0% -31.6% -28.4% 69.3%
EBITDA Margin -4.3% -4.1% -4.5% -9.8% -17.8% -19.7% -40.0% -92.8% -30.4% -35.5% -31.6% 66.1%
FCF Margin -3.9% -4.3% -4.2% -5.1% -6.7% -9.5% -15.6% -25.0% -30.6% -33.6% -32.6% -36.9% -15.5% -10.8% -3.1% 9.4%
OCF Margin -3.8% -4.2% -4.1% -5.0% -6.5% -9.3% -15.3% -24.5% -30.4% -33.4% -32.4% -36.7% -15.3% -10.7% -2.8% 9.8%
ROE 3Y Avg snapshot only -21.43%
ROE 5Y Avg snapshot only -32.28%
ROA 3Y Avg snapshot only -19.85%
ROIC Economic snapshot only -19.24%
Cash ROA snapshot only -17.35%
Cash ROIC snapshot only -20.26%
CROIC snapshot only -20.36%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -4.66 -13.75 -8.88 -10.71 -1.92 -3.49 -3.45 -1.57 -2.07 -2.78 -4.29 -5.89 -19.48 -12.44 -26.08 -352.82 -5.88 -8.10 -9.57 -7.68 -6.579
P/S Ratio 22.44 56.34 37.46 56.66 13.85 34.89 59.78 42.08 67.01 104.81 148.89 233.12 4.83 2.76 3.17 2.25 0.000
P/B Ratio 3.59 10.85 3.39 4.54 0.95 1.77 1.91 0.86 1.03 1.38 1.78 2.49 1.68 0.95 1.04 0.74 1.77 2.37 2.05 1.67 1.502
P/FCF -5.72 -13.22 -8.95 -11.17 -2.08 -3.68 -3.83 -1.69 -2.19 -3.12 -4.57 -6.33 -31.24 -25.49 -101.60 23.80 -6.60 -9.53 -11.87 -9.15 -9.151
P/OCF 23.04
EV/EBITDA -3.22 -12.66 -6.36 -8.49 0.17 -1.48 -1.73 0.17 -0.14 -0.78 -1.77 -3.26 -5.47 0.10 -1.38 8.63 -2.61 -4.74 -4.86 -3.06 -3.059
EV/Revenue 15.03 50.18 26.08 43.80 -1.23 14.53 29.90 -4.77 4.74 32.45 68.53 143.32 2.07 -0.03 0.26 -0.66
EV/EBIT -3.11 -12.22 -6.16 -8.26 0.17 -1.45 -1.69 0.17 -0.13 -0.77 -1.74 -3.20 -5.15 0.09 -1.25 6.95 -2.56 -4.65 -4.78 -3.01 -3.006
EV/FCF -3.83 -11.77 -6.23 -8.63 0.18 -1.53 -1.92 0.19 -0.15 -0.97 -2.10 -3.89 -13.38 0.30 -8.49 -6.94 -3.03 -5.69 -6.14 -3.74 -3.737
Earnings Yield -21.4% -7.3% -11.3% -9.3% -52.0% -28.7% -29.0% -63.9% -48.3% -36.0% -23.3% -17.0% -5.1% -8.0% -3.8% -0.3% -17.0% -12.3% -10.5% -13.0% -13.02%
FCF Yield -17.5% -7.6% -11.2% -9.0% -48.1% -27.2% -26.1% -59.3% -45.7% -32.1% -21.9% -15.8% -3.2% -3.9% -1.0% 4.2% -15.2% -10.5% -8.4% -10.9% -10.93%
PEG Ratio snapshot only 0.003
Price/Tangible Book snapshot only 1.675
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 4.23 4.23 11.77 11.77 11.77 11.77 12.41 12.41 12.41 12.41 17.71 17.71 17.71 17.71 22.63 22.63 22.63 22.63 27.40 27.40 27.397
Quick Ratio 4.33 4.33 11.80 11.80 11.80 11.80 12.41 12.41 12.41 12.41 17.71 17.71 17.71 17.71 22.63 22.63 22.63 22.63 27.40 27.40 27.397
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.07 0.07 0.07 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.02 0.02 0.018
Net Debt/Equity -1.19 -1.19 -1.03 -1.03 -1.03 -1.03 -0.95 -0.95 -0.95 -0.95 -0.96 -0.96 -0.96 -0.96 -0.96 -0.96 -0.96 -0.96 -0.99 -0.99 -0.991
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.06 0.06 0.06 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.018
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.12 -0.12 -0.13 -0.12 -0.10 -0.10 -0.35 -0.41 -0.56 -1.42 -0.11 -0.12 -0.08 -0.08 -0.083
Net Debt/EBITDA 1.59 1.55 2.78 2.49 2.14 2.07 1.73 1.70 1.81 1.75 2.08 2.04 7.30 8.45 15.11 38.25 3.06 3.21 4.54 4.43 4.432
Interest Coverage
Equity Multiplier 1.36 1.36 1.11 1.11 1.11 1.11 1.14 1.14 1.14 1.14 1.10 1.10 1.10 1.10 1.07 1.07 1.07 1.07 1.05 1.05 1.050
Cash Ratio snapshot only 27.001
Cash to Debt snapshot only 54.680
FCF to Debt snapshot only -9.915
Defensive Interval snapshot only 1491.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.13 0.15 0.11 0.09 0.08 0.06 0.03 0.02 0.01 0.01 0.01 0.01 0.34 0.33 0.31 0.31 0.00 0.00 0.00 0.00 0.000
Inventory Turnover 675.23 690.04
Receivables Turnover 11.54 13.88 6.21 5.50 4.69 3.47 3.28 2.09 1.57 1.35 7.32 6.55 213.13 211.15 60.77 60.77 0.00 0.00 0.00 0.00 0.000
Payables Turnover 20.91 21.37 15.72 16.06 17.78 17.40 18.23 17.96 16.26 16.94 16.67 11.59 11.41 5.71 9.24 8.99 0.34 0.34 0.00 0.25 0.245
DSO 32 26 59 66 78 105 111 174 232 269 50 56 2 2 6 6
DIO 1 1 -9 -8 -8 -8 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 0.0 days
DPO 17 17 23 23 21 21 20 20 22 22 22 31 32 64 40 41 1070 1070 1488 1488.1 days
Cash Conversion Cycle 15 10 27 35 50 76 90 153 208 247 28 24 -30 -62 -34 -35
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 4.5% 3.0% 1.2% 31.9% -5.1% -41.5% -66.9% -76.2% -79.0% -75.6% -55.8% -37.9% 25.8% 29.9% 27.5% 30.9% -1.0% -1.0% -1.0% -1.0% -1.00%
Net Income -9.8% -8.5% -14.2% -29.4% -42.1% -42.8% -35.9% -21.1% 5.5% 7.9% 11.4% 8.6% 79.4% 81.9% 90.0% 99.5% -2.6% -3.0% -6.7% -148.2% -148.25%
EPS 19.8% 19.2% 22.5% -0.3% -13.4% -13.1% -5.9% 17.6% 37.5% 31.2% 25.4% 11.9% 80.0% 82.0% 88.5% 99.5% -2.7% -3.0% -5.6% -121.3% -121.35%
FCF -24.7% -98.7% -45.8% -54.5% -61.2% -30.0% -23.5% -17.3% 3.2% 13.3% 7.6% 8.4% 86.5% 90.1% 97.3% 1.1% -4.2% -5.9% -23.2% -9.5% -9.45%
EBITDA -8.1% -7.2% -13.4% -29.9% -43.7% -44.8% -39.7% -27.5% -2.6% -3.0% 1.1% 1.0% 70.5% 75.4% 85.8% 94.5% -1.5% -1.7% -4.0% -11.8% -11.85%
Op. Income -7.9% -7.1% -13.2% -28.8% -42.0% -43.7% -38.9% -27.2% -2.9% -2.3% 1.7% 1.7% 69.5% 72.5% 80.2% 88.9% -1.6% -1.7% -2.9% -5.9% -5.94%
OCF Growth snapshot only -9.14%
Asset Growth snapshot only 40.49%
Equity Growth snapshot only 43.60%
Debt Growth snapshot only -25.33%
Shares Change snapshot only 21.98%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 75.4% 3.4% -17.1% -31.7% -42.0% 75.0% 64.0% 61.0% 67.7%
Revenue 5Y 1.5%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 39.9% 27.1% 27.1% 27.1% 27.1% 25.8% 25.8% 25.8% 25.8% 3.5% 3.5% 3.5% 3.5% 17.3% 17.3% 17.35%
Assets 5Y 24.6% 18.7% 18.7% 18.7% 18.7% 23.1% 23.1% 23.10%
Equity 3Y 40.7% 31.7% 31.7% 31.7% 31.7% 35.2% 35.2% 35.2% 35.2% 4.7% 4.7% 4.7% 4.7% 20.6% 20.6% 20.61%
Book Value 3Y 2.3% -0.3% -4.6% -4.1% 0.2% 3.2% 7.9% 8.2% 13.2% -4.8% -9.3% -9.1% -5.3% 13.0% 11.2% 11.19%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.92 1.00 0.92 0.70 0.56 0.23 0.06 0.00 0.06 0.32 0.67 0.46 0.43 0.41 0.40 0.09 0.08 0.07 0.05 0.048
Earnings Stability 0.82 0.90 1.00 0.88 0.91 0.96 1.00 0.78 0.81 0.81 0.85 0.10 0.03 0.00 0.04 0.06 0.09 0.10 0.11 0.112
Margin Stability 0.00 0.19 0.49 0.34 0.00 0.21 0.03 0.28 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.002
Rev. Growth Consistency 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.97 0.94 0.88 0.83 0.83 0.86 0.92 0.98 0.97 0.95 0.97 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend -0.28 0.18 0.23 0.28 0.28 0.01 0.03 0.14 0.15 0.05 0.06 0.41 0.43 0.44 0.48 -0.01 -0.01 0.01 -0.01 -0.006
Gross Margin Trend 17.17 4.20 -0.65 -6.94 -14.24 -17.64 -21.83 -11.13 -3.32 13.53 17.00 15.33 16.52
FCF Margin Trend 19.50 4.02 -3.08 -10.40 -20.25 -25.35 -26.75 -22.71 -21.84 18.50 21.44 24.08 31.00
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.80 1.02 0.97 0.94 0.90 0.93 0.88 0.91 0.94 0.89 0.93 0.93 0.62 0.48 0.23 -15.31 0.89 0.84 0.80 0.84 0.835
FCF/OCF 1.02 1.02 1.02 1.02 1.03 1.02 1.02 1.02 1.01 1.01 1.01 1.00 1.01 1.01 1.13 0.97 1.00 1.01 1.01 1.01 1.005
FCF/Net Income snapshot only 0.839
CapEx/Revenue 9.1% 9.1% 8.9% 10.0% 16.9% 22.1% 31.0% 46.7% 25.1% 20.9% 18.1% 14.5% 0.2% 0.2% 0.3% 0.3%
CapEx/Depreciation snapshot only 0.234
Accruals Ratio -0.12 0.01 -0.01 -0.03 -0.06 -0.04 -0.06 -0.04 -0.03 -0.05 -0.03 -0.03 -0.03 -0.04 -0.03 -0.03 -0.03 -0.04 -0.05 -0.04 -0.040
Sloan Accruals snapshot only 0.332
Cash Flow Adequacy snapshot only -197.385
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -15.5% -18.3% -25.5% -14.1% -67.6% -21.6% -21.3% -1.2% -97.2% -42.7% -28.2% -0.3% -0.6% -1.3% -1.1% -0.6% -0.2% -0.1% -23.5% -28.9% -28.86%
Total Shareholder Return -15.5% -18.3% -25.5% -14.1% -67.6% -21.6% -21.3% -1.2% -97.2% -42.7% -28.2% -0.3% -0.6% -1.3% -1.1% -0.6% -0.2% -0.1% -23.5% -28.9% -28.86%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 0.98 0.95 0.92 0.89 0.88 0.88 0.62 0.63 0.57 0.07 0.95 0.96 0.96 0.96 0.959
EBIT Margin -4.83 -4.11 -4.23 -5.31 -7.23 -10.05 -17.68 -28.20 -35.21 -42.26 -39.45 -44.84 -0.40 -0.35 -0.21 -0.09
Asset Turnover 0.13 0.15 0.11 0.09 0.08 0.06 0.03 0.02 0.01 0.01 0.01 0.01 0.34 0.33 0.31 0.31 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.32 1.32 1.19 1.19 1.19 1.19 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.08 1.08 1.08 1.08 1.06 1.06 1.059
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.25 $-2.05 $-1.99 $-2.21 $-2.55 $-2.32 $-2.11 $-1.82 $-1.59 $-1.60 $-1.57 $-1.60 $-0.32 $-0.29 $-0.18 $-0.01 $-1.17 $-1.14 $-1.18 $-1.00 $-1.00
Book Value/Share $2.92 $2.60 $5.21 $5.20 $5.17 $4.58 $3.82 $3.33 $3.22 $3.22 $3.80 $3.79 $3.70 $3.77 $4.50 $3.89 $3.89 $3.88 $5.51 $4.58 $4.37
Tangible Book/Share $2.92 $2.60 $5.21 $5.20 $5.17 $4.58 $3.82 $3.33 $3.22 $3.22 $3.80 $3.79 $3.70 $3.77 $4.50 $3.89 $3.89 $3.88 $5.51 $4.58 $4.58
Revenue/Share $0.47 $0.50 $0.47 $0.42 $0.35 $0.23 $0.12 $0.07 $0.05 $0.04 $0.05 $0.04 $1.28 $1.30 $1.48 $1.28 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-1.83 $-2.13 $-1.98 $-2.12 $-2.36 $-2.20 $-1.90 $-1.69 $-1.51 $-1.42 $-1.48 $-1.49 $-0.20 $-0.14 $-0.05 $0.12 $-1.04 $-0.97 $-0.95 $-0.84 $-0.84
OCF/Share $-1.79 $-2.09 $-1.93 $-2.08 $-2.30 $-2.15 $-1.86 $-1.66 $-1.50 $-1.42 $-1.47 $-1.49 $-0.20 $-0.14 $-0.04 $0.12 $-1.04 $-0.96 $-0.95 $-0.83 $-0.83
Cash/Share $3.46 $3.08 $5.38 $5.37 $5.34 $4.72 $3.90 $3.40 $3.28 $3.28 $3.82 $3.81 $3.71 $3.79 $4.47 $3.86 $3.85 $3.85 $5.56 $4.62 $4.37
EBITDA/Share $-2.18 $-1.98 $-1.94 $-2.15 $-2.50 $-2.28 $-2.11 $-1.87 $-1.70 $-1.75 $-1.75 $-1.78 $-0.49 $-0.43 $-0.29 $-0.10 $-1.21 $-1.16 $-1.20 $-1.02 $-1.02
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.26 $0.22 $0.22 $0.22 $0.17 $0.17 $0.17 $0.17 $0.16 $0.14 $0.14 $0.14 $0.10 $0.08 $0.08
Net Debt/Share $-3.46 $-3.08 $-5.38 $-5.37 $-5.34 $-4.72 $-3.64 $-3.17 $-3.07 $-3.07 $-3.64 $-3.64 $-3.54 $-3.61 $-4.31 $-3.72 $-3.72 $-3.71 $-5.46 $-4.54 $-4.54
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 18.434
Altman Z-Prime snapshot only 34.935
Piotroski F-Score 4 4 5 3 2 2 2 2 3 3 5 4 6 5 6 6 4 3 3 3 3
Beneish M-Score 7.47 7.29 -2.37 -2.31 -1.97 0.32 -3.87 -3.78 -3.44 -3.53 -35.34 63.32
Ohlson O-Score snapshot only -2.382
ROIC (Greenblatt) snapshot only -22.59%
Net-Net WC snapshot only $4.46
EVA snapshot only $-68689780.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 60.39 73.71 89.00 89.00 84.13 89.00 76.78 49.39 53.85 64.89 76.71 76.44 76.56 76.30 76.29 83.04 76.42 76.04 76.15 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only -7.432
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms